SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration on December 6, 2022, for use of the ...
This is very exciting! The good activity and highly conserved epitope of this antibody suggested its potential for clinical translation". The team found the mAb-39 greatly improved the neutralizing ...
A research team has successfully developed the world's first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform. Subscribe to our newsletter for the latest sci-tech news updates ...
Imagine the last time you went to the doctor feeling miserable with a cold. If you have ever heard “you have a virus” from your physician, you know exactly what that means. There are no antibiotics ...
When some viruses infect our bodies, “our immune system can create a type of ‘permanent immunity’, meaning that once you’ve been exposed to that virus, you’ve got protection from it and are typically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results